首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷手術用器具內視鏡檢查設備

市場調查報告書

商品編碼

1373400

全球內視鏡血管採集設備市場 - 2023-2030

Global Endoscopic Vessel Harvesting Devices Market - 2023-2030

出版日期: 2023年10月18日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

大隱靜脈 (GSV) 是冠狀動脈繞道手術中最常用的導管，透過內視鏡靜脈採集 (EVH) 方法採集。利用微小切口和類似鈍器解剖器的內視鏡攝影機在皮膚下製作皮下組織隧道來執行此手術。該練習描述了該程序的基本步驟以及執行該程序的醫療團隊的職責。

由於內視鏡技術的不斷發展，視覺品質、器械移動性和血管採集手術的整體有效性都得到了改善。由於這些發展，內視鏡血管採集現在變得更安全、更有效率。微創外科手術的優勢，例如切口更小、疤痕更少、恢復更快，正促使更多患者尋求這種手術。為了滿足患者的需求，外科醫生擴大使用內視鏡血管採集裝置。

市場動態：促進因素

冠狀動脈繞道手術 (CABG) 手術的需求不斷增加

大隱靜脈 (GSV) 是冠狀動脈繞道手術 (CABG) 手術中最常用的導管，在過去十年中一直透過內視鏡靜脈採集 (EVH) 收集。由於隱靜脈的長度和採集的簡單性，隱靜脈經常被利用。由於患者進行大量冠狀動脈繞道手術的必要性不斷增加以及全球對冠狀動脈繞道手術的需求不斷增加，對更多更好導管的需求也不斷成長。

主要參與者正在提供產品來滿足市場上設備的需求。例如，Vasoview Hemopro 2 內視鏡血管採集 (EVH) 系統採用最先進的人體工學設計。它是隱靜脈和橈動脈血管採集的行業標準，具有出色的可操作性和卓越的可視性，使採集器能夠更有效率地工作，從而獲得更好的患者治療效果。

此外，建議在微創手術過程中使用Saphena Medical Venapax內視鏡血管採集系統。主要適用於接受內視鏡動脈繞道手術的患者，以取得血管。用於冠狀動脈繞道手術的沿隱靜脈的組織解剖和用於冠狀動脈搭橋術的周邊動脈繞道術或橈動脈的組織解剖是四肢手術的例子。

心血管疾病的盛行率不斷增加

根據世界衛生組織的數據，心血管疾病 (CVD) 是全球死亡的主要原因，每年有 1,790 萬人死亡。冠心病、腦血管疾病、風濕性心臟病和其他疾病都屬於心臟和血管疾病，稱為CVD。每 5 例 CVD 死亡中就有超過 4 例是由心臟病發作和中風造成的，其中三分之一的死亡發生在 70 歲之前。

此外，心血管疾病治療的技術進步也推動了市場的發展。例如，根據《2023年可視化外科雜誌》報道，在過去的幾十年裡，冠狀動脈手術經歷了顯著的發展。許多這些進展改善了患者的移植物通暢性並降低了心臟手術的發生率。機器人完全內視鏡冠狀動脈繞道手術（TECAB）移植是一種治療方法，外科醫生使用手術機器人完成所有主要手術過程，包括使用內視鏡端口切口進行吻合縫合。

限制因素

內視鏡血管採集設備市場在經歷成長的同時，也面臨各種可能阻礙其發展和採用的限制因素。這些因素包括設備成本高、缺乏熟練的外科醫生、安全問題、替代技術、監管障礙和有限的臨床證據。

The greater saphenous vein (GSV), the conduit most frequently utilized in coronary artery bypass graft surgery, is harvested via an endoscopic vein harvesting (EVH) method. A subcutaneous tissue tunnel is made under the skin utilizing tiny incisions and an endoscopic camera that resembles a blunt dissector to execute this surgery. The exercise describes the procedure's essential steps as well as the responsibilities of the medical team performing it.

The quality of vision, instrument mobility, and general effectiveness of vessel harvesting procedures have all increased as a result of ongoing developments in endoscopic technology. Endoscopic vessel harvesting is now safer and more efficient thanks to these developments. The perceived advantages of minimally invasive surgical procedures, such as smaller incisions, less scarring, and speedier recovery, are leading more patients to ask for them. To suit patient needs, surgeons are increasingly likely to use endoscopic vascular harvesting devices.

Market Dynamics: Drivers

Increasing Demand Coronary Artery Bypass Graft (CABG) Surgery

The greater saphenous vein (GSV), which is the most often used conduit in coronary artery bypass graft (CABG) surgery, has been harvested via endoscopic vein harvesting (EVH) over the past ten years. Due to their length and simplicity of harvesting, the saphenous veins are frequently exploited. The need for more and better conduits has grown as a result of the rising necessity for numerous coronary artery bypass surgeries among patients and the global demand for CABG operations.

The key players are offering the product to meet the demand of devices in the market. For instance, the Vasoview Hemopro 2 Endoscopic Vessel Harvesting (EVH) System features the most advanced ergonomic design available. It is the industry standard for both saphenous vein and radial artery vessel harvesting, offering great maneuverability and superb visibility to let harvesters work more productively and effectively for better patient outcomes.

In addition, it is recommended to use the Saphena Medical Venapax endoscopic vessel harvesting system during minimally invasive surgery. Primarily for patients undergoing endoscopic surgery for artery bypass, giving access to vascular harvesting. Tissue dissection along the saphenous vein for coronary artery bypass grafting and peripheral artery bypass or radial artery for coronary artery bypass grafting are examples of extremity surgeries.

The Increasing Prevalence of Cardiovascular diseases

According to World Health Organization, with 17.9 million deaths per year, cardiovascular diseases (CVDs) are the leading cause of death worldwide. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the category of heart and blood vessel disorders known as CVDs. Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70.

In addition, the technological advances in the treatment of cardiovascular disease drive the market. For instance, as per the Journal of Visualized Surgery in 2023, Over the past few decades, coronary artery surgery has undergone significant development. Numerous of these developments have improved graft patency for patients and reduced the morbidity of cardiac surgery. Robotic completely endoscopic coronary artery bypass (TECAB) grafting is a treatment in which surgeons use a surgical robot to complete all major surgical processes, including anastomotic suturing, using endoscopic port site incisions.

Restraining Factors

The endoscopic vessel harvesting devices market, while experiencing growth, also faces various restraint factors that can hinder its development and adoption. The factors such as high cost of devices, lack of skilled surgeons, safety concerns, alternative techniques, regulatory hurdles, and limited clinical evidence.

Segment Analysis

The global endoscopic vessel harvesting devices market is segmented based on product type, application, end-user and region.

The EVH Systems segment accounted for approximately 45.8% of the market share

The greater saphenous vein (GSV), the conduit most frequently used in coronary artery bypass graft surgery, is harvested via an endoscopic vein harvesting (EVH) method. An endoscopic camera, such as a blunt dissector, must be used in conjunction with minor incisions to create a tunnel of subcutaneous tissue beneath the skin during this surgery. The activity outlines the procedure's essential steps and clarifies the roles of the healthcare team doing it.

By employing an endoscope to view the patient's body, endoscopic tools enable clinicians to carry out minimally invasive surgeries through very small incisions. When performing cardiac surgery, the VirtuoSaph Plus Endoscopic Vessel Harvesting System from Terumo is utilized to remove the patient's saphenous vein or radial artery for use as a bypass graft.

Geographical Penetration

North America segment accounted for approximately 38.6% of the market share

North America has been a dominant force in the global endoscopic vessel harvesting devices market. Infections at the sternal or conduit harvest site incisions were thought to have occurred in between 2% and 20% of coronary artery bypass grafting (CABG) surgeries performed in the United States. Although graft harvest site infections may be more frequent after CABG, deep chest infections and mediastinitis have received a lot of attention due to their potential for significant morbidity and mortality.

Gintage offers Early generation EVH users were taken into consideration during the design of the Vasoview 7xB Endoscopic Vessel Harvesting System. The 7xB platform, with its cutting-edge, responsive controls, enables you to work with confidence and enjoy quick productivity if you are most comfortable using a two-handed configuration.

As of July 2023, CardioPrecision, an expert in transcervical access for the treatment of structural heart disease and cardiothoracic interventions, has taken another significant step by entering the US market, which is currently the largest medical device market by value in the world and represents a significant scale up for the company. This comes after its CoreVista devices were proven to be highly effective in Scotland.

CardioPrecision, a company that was spun off from the NHS through InnoScot Health, recently debuted its technology at the prestigious Massachusetts General Hospital in Boston for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) operations.

COVID-19 Impact Analysis:

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global endoscopic vessel harvesting devices market. In order to conserve resources and reduce the risk of infection for both patients and healthcare professionals during the height of the epidemic, numerous hospitals and healthcare facilities postponed or cancelled elective surgery.

As a result, there were significantly fewer procedures involving coronary artery bypass grafting (CABG), which in turn reduced the demand for endoscopic vascular harvesting equipment.

Competitive Landscape

The major global players in the market include: Getinge, Spectra Group, Terumo Corporation, KARL STORZ SE & Co. KG, Saphena Medical, Medical Instruments Spa, Sorin Group, Medical Instruments Spa, Med Europe S.r.l., and Olympus Corporation among others.

Why Purchase the Report?

To visualize the global endoscopic vessel harvesting devices market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of endoscopic vessel harvesting devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global endoscopic vessel harvesting devices market report would provide approximately 61 tables, 56 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-user
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Demand Coronary Artery Bypass Graft (CABG) Surgery
  - 4.1.1.2. The Increasing Prevalence of Cardiovascular Diseases
- 4.1.2. Restraints
  - 4.1.2.1. High Cost
  - 4.1.2.2. Lack of Skilled Surgeons
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Patent Analysis
5.8. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. EVH Systems*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Accessories
7.4. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Coronary Artery Bypass Grafting (CABG)*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Peripheral Artery Bypass Surgery

9. By End-user

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.1.2. Market Attractiveness Index, By End-user
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers (ASCs
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Getinge*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Spectra Group
12.3. Terumo Corporation
12.4. KARL STORZ SE & Co. KG
12.5. Saphena Medical
12.6. Medical Instruments Spa
12.7. Sorin Group
12.8. Medical Instruments Spa
12.9. Med Europe S.r.l.
12.10. Olympus Corporation

LIST NOT EXHAUSTIVE